For self-insured employers, heart disease and diabetes are considered significant hindrances in the effort to improve employee health while reducing overall healthcare costs. Heart disease is the leading cause of death for both men and women and about 9.4% of Americans are diagnosed with diabetes. In order to control cost and help employees, employers typically look to disease state management programs. While many of these programs seem beneficial, the durability and long-term effects have limited evaluation.
What is a disease management program?
Disease management programs (DMPs) are structured treatment plans that aim to help people better manage their chronic disease and to maintain and improve quality of life. DMPs are also run with the general goal of improving medical treatment in the long term. Disease management programs also aim to improve cooperation between the various specialists and institutions that provide care for a patient, such as family and specialist doctors, hospitals and rehabilitation centers.1
What are the long-term outcomes of a DMP?2
A recent study published in the NCBI had the main objective of assessing the 5-year health, economic, and quality-of-life patient outcomes of an employer-sponsored disease state management program. The program included one-on-one appointments with a pharmacist that included medication therapy management, implementation and adherence to 7 personalized lifestyle medicine programs (ie, physical activity, healthy eating, stress management, restorative sleep, moderate alcohol consumption, tobacco abstinence/cessation, and weight control), and chronic disease care coordination practices.
The results of the study identified:
- Decreased low-density lipoprotein cholesterol levels: 96.71 mg/dL vs 84.83 mg/dL, respectively
- Increased high-density lipoprotein cholesterol levels: 39.32 mg/dL vs 46.12 mg/dL
- Decreased systolic blood pressure: 132.04 mm Hg vs 123.63 mm Hg
- Average exercise time increased: 50 minutes weekly vs 156.04 minutes weekly
- The combined healthcare and productivity return on investment for the program at 5 years was $9.64 for every $1 invested.
What is the difference between a Disease Management program and the Chronic Condition Management Program offered by Tria Health?
Tria Health started as a disease management program and has its foundation there, but many disease management programs are focused one particular disease state versus the program offered by Tria Health which is patient-centered. Most patients have more than one chronic condition, so taking a ‘patient-centered’ approach improves overall care and costs.
Interested in improving your employee’s health?
Tria Health offers Chronic Condition Management through our Pharmacy Advocate Program. Clinical Pharmacists provide one-on-one telephonic counseling for members and are their personal advocate to help them navigate through the health care system. Through reviewing a member’s medications and lifestyle, including their sleep habits, Tria Pharmacists can make recommendations that will help control their chronic conditions and help them feel better!